Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Latvijas Zoovetapgade AS Applies for Court Protection
Latvijas Zoovetapgade AS announced that its Management Board has given an application of process of legal protection in Riga City Zemgale District Court on February 18, 2013. Further details were not disclosed.
Latest Developments for Latvijas Zoovetapgade AS
- NASDAQ OMX Riga Removes Additional Reason for Observation Status for Latvijas Zoovetapgade AS
- Latvijas Zoovetapgade AS Announces Details on Insolvency
- Latvijas Zoovetapgade AS Announces Additional Reason for Trading under Surveillance-NASDAQ OMX Riga
- Latvijas Zoovetapgade AS Announces Additional Reason for Trading under Surveillance-NASDAQ OMX Riga
Latest Key Developments in Pharmaceuticals
- Takeda Pharmaceutical Co Ltd's Type 2 Diabetes Therapies, NESINA, KAZANO and OSENI Are Available in Pharmacies in the United States
- Valeant Pharmaceuticals International Inc Announces Public Offering Of Common Shares
- S&P Cuts Endo Health Solutions Inc Rating On Aggressive Financial Policies-DJ
- Novo Nordisk A/S Announces Share repurchase programme
- Share this
- Link this
- Digg this
Follow Reuters